Ibuprofen-Loaded Nanogels: Advancing Topical Therapy Through Nanoengineered Drug Delivery Systems

  • Unique Paper ID: 200570
  • Volume: 12
  • Issue: 12
  • PageNo: 2231-2251
  • Abstract:
  • Ibuprofen, a commonly used non-steroidal anti-inflammatory drug (NSAID), exhibits limitations such as poor aqueous solubility (BCS Class II), short half-life, and gastrointestinal side effects, which restrict its therapeutic efficiency. To overcome these challenges, ibuprofen-loaded nanogels have been developed as an advanced drug delivery system for enhanced localized and transdermal delivery. These nanogels are prepared using high-energy methods (such as high-pressure homogenization, microfluidization, and ultrasonication) and low-energy techniques (including phase inversion and self-nanoemulsification), forming a stable three-dimensional polymeric network with key excipients like Carbopol 934 and Tween 80. With particle sizes ranging from 20–200 nm, nanogels improve solubility, provide high drug encapsulation efficiency (>90%), and enable controlled drug release following Higuchi and Korsmeyer–Peppas kinetics. Overall, ibuprofen nanogels enhance dermal permeation, ensure sustained drug release, reduce dosing frequency, and minimize systemic side effects, making them a promising approach for the treatment of localized inflammatory conditions.

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{200570,
        author = {Vaishnavi Balkrishna Tribhuwan and Shantanu Devidas Unche and Dhanashree Sudhakar Waghmode and SHRADDHA BANDU WAKLE and Laveena Makhija},
        title = {Ibuprofen-Loaded Nanogels: Advancing Topical Therapy Through Nanoengineered Drug Delivery Systems},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {12},
        pages = {2231-2251},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=200570},
        abstract = {Ibuprofen, a commonly used non-steroidal anti-inflammatory drug (NSAID), exhibits limitations such as poor aqueous solubility (BCS Class II), short half-life, and gastrointestinal side effects, which restrict its therapeutic efficiency. To overcome these challenges, ibuprofen-loaded nanogels have been developed as an advanced drug delivery system for enhanced localized and transdermal delivery. These nanogels are prepared using high-energy methods (such as high-pressure homogenization, microfluidization, and ultrasonication) and low-energy techniques (including phase inversion and self-nanoemulsification), forming a stable three-dimensional polymeric network with key excipients like Carbopol 934 and Tween 80. With particle sizes ranging from 20–200 nm, nanogels improve solubility, provide high drug encapsulation efficiency (>90%), and enable controlled drug release following Higuchi and Korsmeyer–Peppas kinetics. Overall, ibuprofen nanogels enhance dermal permeation, ensure sustained drug release, reduce dosing frequency, and minimize systemic side effects, making them a promising approach for the treatment of localized inflammatory conditions.},
        keywords = {Ibuprofen, Nanogel, Nanoemulsion, Transdermal Delivery, Carbopol 934, NSAIDs, Controlled Release.},
        month = {May},
        }

Cite This Article

Tribhuwan, V. B., & Unche, S. D., & Waghmode, D. S., & WAKLE, S. B., & Makhija, L. (2026). Ibuprofen-Loaded Nanogels: Advancing Topical Therapy Through Nanoengineered Drug Delivery Systems. International Journal of Innovative Research in Technology (IJIRT), 12(12), 2231–2251.

Related Articles